October 21, 2016 4:19 PM ET


Company Overview of Excelimmune, Inc.

Company Overview

Excelimmune, Inc. develops antibody combination therapeutics for the treatment of monotherapy-resistant infectious and oncological diseases. The company develops Staphguard ACT, a novel treatment for methicillinresistant staphylococcus aureus infection. It offers technology treatments for combination therapies, infectious diseases, oncology, and autoimmunity. Excelimmune, Inc. was incorporated in 2006 and is based in Lexington, Massachusetts.

1776 Massachusetts Avenue

Lexington, MA 02420

United States

Founded in 2006





Key Executives for Excelimmune, Inc.

Chief Executive Officer, President and Chief Scientific Officer
Executive Chairman
Age: 68
Chief Financial Officer and Vice President of Corporate Development
Vice President of Product Development
Age: 53
Director of Antibody Technologies
Compensation as of Fiscal Year 2016.

Excelimmune, Inc. Key Developments

Catalent and Excelimmune Inc Sign Licensing Agreement for ACT Tech Platform

Catalent Inc. announced that it had entered into an exclusive licensing agreement giving it access to the antibody combination therapy (ACT) technology platform developed by Excelimmune Inc. The terms of the deal, whose financial value was not disclosed, envision Catalent continuing development work on the platform, both internally and through partner-sponsored programmes. Catalent can advance that development by leveraging its own GPEx technology.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Excelimmune, Inc., please visit www.excelimmune.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.